NCT02194803
- Conditions
- Neovascular AMD, Visual Impairment Due to DME, Visual Impairment Due to Macular Oedema Secondary to Branch or Central RVO, Visual Impairment Due to CNV
- Locations
-
- Novartis Investigative Site Tübingen, Germany
Clinical trial condition
Neovascular AMD, Visual Impairment Due to DME, Visual Impairment Due to Macular Oedema Secondary to Branch or Central RVO, Visual Impairment Due to CNV
Explore clinical trials studying Neovascular AMD, Visual Impairment Due to DME, Visual Impairment Due to Macular Oedema Secondary to Branch or Central RVO, Visual Impairment Due to CNV. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies